Ruth Soferman

Ruth Soferman

Auto-generated profile, based on publicly available information

Ruth Soferman

Sackler Faculty of Medicine, Department of Pediatric Pulmonology, Critical Care and Sleep Medicine, Dana Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2008 in Pediatrics International
Verified
Journal Article
Closed access
PDF file
RSRuth Soferman
Ruth Soferman
MGMiguel Glatstein
Miguel Glatstein
YSYakov Sivan
Yakov Sivan
YWYosef Weisman
Yosef Weisman

1 December 2003 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
RSRuth Soferman
Ruth Soferman
LBLiat Ben-Sira
Liat Ben-Sira
UJUri Jurgenson
Uri Jurgenson


20 November 2014 in Journal of Asthma
Verified
Journal Article
Closed access
PDF file
KAKeren Armoni-Domany
Keren Armoni-Domany
GGGuy Gut
Guy Gut
RSRuth Soferman
Ruth Soferman
YSYakov Sivan
Yakov Sivan
Objective: No consensus guidelines exist for the respiratory treatment of asthmatic children referred for elective surgery. The aim of this study was to evaluate the attitude of pediatric pulmonologists regarding the pre-operative management of these children. Methods: A survey of pre-operative management of asthmatic children was conducted. All 48 certified pediatric pulmonologists in Israel completed a questionnaire that comprised 20 questions regarding their approach to pre-operative management including six case scenarios with a variety of clinical situations and treatments of children with asthma. Results: Response rate was 100%. All believed that pre-operative treatment should be considered in all asthmatic children. Almost 50% suggested that a pediatric pulmonologist should be consulted in all pre-operative assessments. 50% recommended consultation only in individual cases. Overall, results showed a very wide variability between responders especially in pre-school and poorly controlled school children. The variability referred to the use of bronchodilators, inhaled corticosteroids and their combination during the pre-operative days, the addition of systemic CS and the length of pre-operative treatment. Almost all participants suggested either the initiation or augmentation of pre-operative treatment in high risk situations. Conclusions: This data demonstrate an important variability among pediatric pulmonologists in Israel regarding the practice of pre-operative treatment of infants and children with asthma especially for the less controlled and high risk children. This is most probably explained by the paucity of evidence-based data and the lack of established guidelines. Consensus guidelines for the pre-operative management of asthmatic children are needed.

15 December 2007 in Allergy, Asthma & Clinical Immunology
Verified
Journal Article
Open access
PDF file
RSRuth Soferman
Ruth Soferman
IRIdit Rosenzwig
Idit Rosenzwig
EFElizabeth Fireman
Elizabeth Fireman
Interleukin-12 (IL-12) was measured in 45 asthmatic children aged 3 to 16 years. The assessments were performed on 20 children during an episode of acute exacerbation and on 25 children during remission. There was no significant difference between the mean IL-12 level during exacerbation (1.63 ± 2.08 pg/mL) and during remission (0.88 ± 0.56 pg/mL) (p= .83). A positive, but insignificant, correlation was found between forced expiratory volume in 1 second and IL-12 (p= .634). IL-12 levels were significantly lower in children with a positive family history of asthma (1.13 ± 1.78 pg/mL) compared with those without (1.31 ± 1.06 pg/mL) (p< .012), supporting the theory that the gene-environment interactions affect the immune responses. IL-12 peripheral blood levels had no detectable impact on the course of established asthma in the study population.